Latest Psoriasis Stories
Psoriasis Foundation will drive efforts to cure psoriatic disease, help those affected PORTLAND, Ore., July 9, 2014 /PRNewswire-USNewswire/ -- National Psoriasis Foundation will double the
Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit.
Women with long-term high blood pressure (hypertension) appear to be at an increased risk for the skin condition psoriasis, and long-term use of beta (β)-blocker medication to treat hypertension may also increase the risk of psoriasis.
- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical
Patient advocacy group teams with The Dermatologist to educate healthcare providers on the specifics of psoriasis research and treatment. Malvern, PA (PRWEB)
NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a
GURNEE, Ill., June 25, 2014 /PRNewswire/ -- Quest Products announces the national launch of ProVent® Eczema and Psoriasis Spray®, a spray formulated to help minimize the appearance of skin
Doctors at Yale University administered treatment for a non-curable disease (alopecia universalis) in a 25-year-old man that left him without any hair. After the treatment, the man grew a full head of hair.
~Expert panel shares tips, encouraging patients to take a 360° approach to managing their disease and to not give up until they're satisfied~
-- Latest psychological research reveals rosacea redness creates negative first impressions putting sufferers at a disadvantage -- Rosacea remains under-diagnosed, yet diagnosis